Amgen Ventures

Amgen Ventures is the corporate venture capital arm of Amgen, a global biotechnology company. Founded in 2004, the fund invests in emerging biotechnology companies to advance promising new medicines and technologies. Its investment areas include therapeutics, drug discovery platforms, and digital health, with a focus on Amgen's strategic therapeutic areas: oncology, inflammation, cardiovascular disease, neuroscience, bone health, and metabolic disorders. The fund provides early-stage capital and access to Amgen's scientific and development expertise. Since its inception, Amgen Ventures has invested in over 70 companies.